ASHLEY RADMALL: Open Payments
NPI 1346824950 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,904 in 48 payments from 17 companies in 2025. Trend: 2023 $2,081 · 2024 $2,366 · 2025 $2,904
Consulting: $1,943Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $1,972 |
| Amgen Inc. | 10 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $142 |
| CorMedix Inc. | 1 | $122 |
| ANI Pharmaceuticals, Inc. | 5 | $116 |
| Travere Therapeutics, Inc. | 2 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Vifor Pharma, Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $39 |
| Fresenius USA Marketing, Inc. | 2 | $35 |
Products named: TARPEYO, Kerendia, DEFENCATH, PURIFIED CORTROPHIN GEL, TAVNEOS, KRYSTEXXA, FARXIGA, Veltassa.
Industry payments across UT — which companies pay providers there.
